Skip to main content
Aurobindo Pharma Ltd. logo

Aurobindo Pharma Ltd. — Investor Relations & Filings

Ticker · AUROPHARMA ISIN · INE406A01037 LEI · 335800G4T2A353RDGM23 BSE.NS Manufacturing
Open in API
Filings indexed 1,454 across all filing types
Latest filing 2026-05-27 Call Transcript
Country IN India
Listing BSE.NS AUROPHARMA

About Aurobindo Pharma Ltd.

https://www.aurobindo.com/

Aurobindo Pharma Ltd. focuses on the development, manufacturing, and commercialization of generic formulations and active pharmaceutical ingredients (APIs). The company maintains a diverse product portfolio spanning key therapeutic areas, including antibiotics, antiretrovirals, cardiovascular, central nervous system, gastroenterology, and anti-diabetics. With a strong emphasis on vertical integration, the organization manages a comprehensive supply chain from basic chemicals to finished dosage forms. It operates advanced research and development centers and manufacturing facilities that comply with international regulatory standards. The company serves a broad international market, providing cost-effective healthcare solutions through an extensive pipeline of Abbreviated New Drug Applications (ANDAs) and a robust distribution network.

Recent filings

Filing Released Lang Actions
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 90% confidence The document is a full transcript of Aurobindo Pharma’s Q4 FY26 earnings conference call, including management’s opening remarks, detailed financial discussion, and Q&A session. It was filed with stock exchanges to disclose the call transcript. This clearly fits the definition of a Call Transcript (CT).
2026-05-27 English
Submission of earning calls transcript.
Call Transcript Classification · 95% confidence The document is a full text transcript of the company’s Q4 FY26 earnings conference call, including management’s prepared remarks and a Q&A session. It is not a brief earnings release but a verbatim transcript of the call. Therefore, it falls under the Call Transcript category.
2026-05-27 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 90% confidence The document is a notification to the stock exchanges regarding company officials’ participation in an upcoming investor meeting. It does not provide financial results, corporate governance materials, board changes, or specific report data. It is a generic regulatory announcement. Therefore, it fits under Regulatory Filings (RNS) as a miscellaneous disclosure.
2026-05-27 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 85% confidence The document is a brief stock exchange notice informing the listing departments of NSE and BSE about the company’s participation in an upcoming investor meeting (BofA 2026 India Conference). It contains no financial statements, no detailed report, and no regulatory certification. It is a general regulatory announcement falling under the fallback category for miscellaneous exchange filings. Therefore, it should be classified as a Regulatory Filing (RNS).
2026-05-27 English
Intimation of Investor meet at Investec US Pharma and Healthcare Bus Tour 7.0 in New Jersey, USA.
Regulatory Filings Classification · 85% confidence The document is a stock exchange filing dated May 27, 2026, informing NSE and BSE of the company’s participation in an upcoming investor meeting (Investec US Pharma and Healthcare Bus Tour). It contains no financial statements, results, or substantive data; instead it’s a regulatory update/notice. This fits the “Regulatory Filings” fallback category (RNS), as it does not match any specific report type and is an announcement to the exchange.
2026-05-27 English
Intimation of Participation in Investor meet at BofA 2026 India Conference at Mumbai
Regulatory Filings Classification · 85% confidence The document is a formal notice to stock exchanges informing them of company officials’ participation in an upcoming investor meeting. It does not present financial results, report data, governance details, nor is it a report publication announcement or a specific report. It is a compliance/regulatory announcement to stock exchanges regarding investor relations activity, fitting the fallback category for miscellaneous regulatory filings.
2026-05-27 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.